IRIS
MALATESTA, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 628
EU - Europa 532
AS - Asia 342
SA - Sud America 6
OC - Oceania 2
Totale 1.510
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 624
CN - Cina 128
SG - Singapore 113
UA - Ucraina 92
IE - Irlanda 91
SE - Svezia 66
IT - Italia 65
GB - Regno Unito 63
TR - Turchia 58
FR - Francia 55
DE - Germania 41
IN - India 36
FI - Finlandia 21
RU - Federazione Russa 19
BE - Belgio 5
CZ - Repubblica Ceca 5
BR - Brasile 4
CA - Canada 3
IL - Israele 3
AT - Austria 2
AU - Australia 2
CL - Cile 2
VN - Vietnam 2
CH - Svizzera 1
GR - Grecia 1
LB - Libano 1
LI - Liechtenstein 1
LT - Lituania 1
MX - Messico 1
NL - Olanda 1
NO - Norvegia 1
PK - Pakistan 1
PL - Polonia 1
Totale 1.510
Salva come PNG Salva come JPEG
Città #
Chandler 143
Singapore 106
Jacksonville 103
Dublin 91
Southend 52
Beijing 36
Princeton 36
Nanjing 34
Ashburn 32
Izmir 32
Santa Clara 20
Altamura 18
Cambridge 18
Boardman 17
Dearborn 16
Ann Arbor 14
Wilmington 12
Nanchang 11
New York 8
Munich 7
Tianjin 7
Helsinki 6
Los Angeles 6
Shenyang 6
Woodbridge 6
Brussels 5
Hangzhou 5
Hebei 5
Kunming 5
Collecorvino 4
Milan 4
Washington 4
Brno 3
Orange 3
Squinzano 3
Tappahannock 3
Aprilia 2
Changchun 2
Changsha 2
Council Bluffs 2
Dong Ket 2
Edinburgh 2
Fairfield 2
Grevenbroich 2
Jinan 2
Ningbo 2
Norwalk 2
Ottawa 2
Zhengzhou 2
Andover 1
Augusta 1
Barbosa 1
Beirut 1
Brdo 1
Brisbane 1
Chieti 1
Chongqing 1
Civitanova Marche 1
Clearwater 1
Eden Prairie 1
Faisalabad 1
Frankfurt am Main 1
Guarulhos 1
Hefei 1
Jiaxing 1
Kemerovo 1
Kraków 1
Lanzhou 1
Las Vegas 1
Laurel 1
Leawood 1
London 1
Mexico City 1
Mossoró 1
Olomouc 1
Orlando 1
Palermo 1
Perm 1
Qingzhou 1
Reston 1
Rome 1
Romola 1
San Mateo 1
Seattle 1
Serafina Corrêa 1
Serio 1
Taizhou 1
Toronto 1
Turin 1
Yaroslavl 1
Totale 948
Salva come PNG Salva come JPEG
Nome #
Effective assessment of egfr mutation status in bronchoalveolar lavage and pleural fluids by next-generation sequencing. 116
ALK rearrangement testing by FISH analysis in non-small-cell lung cancer patients: Results of the first italian external quality assurance scheme 109
Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: Toward a real-time liquid biopsy for treatment 104
A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer. 102
A unique microRNA signature associated with ischemic stroke in humans 101
A unique microRNA signature associated with plaque instability in humans. 98
HIGH-RISK HUMAN PAPILLOMA VIRUS INFECTION, TUMOR PATHOPHENOTYPES AND BRCA1/2 AND P53 STATUS IN JUVENILE BREAST CANCER PATIENTS. 92
ATP-binding cassette transporter A1 (ABCA1) overexpression in hypercholesterolemic plaques: a potential molecular explanation 92
Reduction of atherothrombotic burden before stent deployment in non-ST elevation acute coronary syndromes: Reduction of myocardial necrosis achieved with nose-dive manual thrombus aspiration (REMNANT) trial. A volumetric intravascular ultrasound study 84
Mutational profile of GNAQQ209 in human tumors. 81
Clinical features and outcome of patients with non-small-cell lung cancer harboring BRAF mutations. 77
Frequent mutations in the neurotrophic tyrosine receptor kinase gene family in large cell neuroendocrine carcinoma of the lung. 76
Complex Mutations & Subpopulations of Deletions at Exon 19 of EGFR in NSCLC Revealed by Next Generation Sequencing: Potential Clinical Implications. 76
IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors. 73
EGFR molecular profiling in advanced NSCLC: a prospective phase II study in molecularly/clinically selected patients pretreated with chemotherapy. 71
microRNAs Derived from Circulating Exosomes as Noninvasive Biomarkers for Screening and Diagnosing Lung Cancer. 69
Increased detection sensitivity for KRAS mutations enhances the prediction of anti-EGFR monoclonal antibody resistance in metastatic colorectal cancer. 68
Clinical implications of KRAS mutations in lung cancer patients treated with tyrosine kinase inhibitors: an important role for mutations in minor clones. 63
Totale 1.552
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.214
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.214
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020109 0 0 0 0 0 0 0 18 5 41 44 1
2020/2021112 20 0 23 2 8 22 0 2 10 15 5 5
2021/202286 2 1 1 20 2 1 0 7 8 11 10 23
2022/2023364 25 57 18 46 41 63 15 23 48 2 13 13
2023/2024168 14 1 12 4 7 57 35 10 0 4 0 24
2024/2025232 16 83 78 10 8 25 3 9 0 0 0 0
Totale 1.552